Literature DB >> 11014431

Abnormal pattern of Tie-2 and vascular endothelial growth factor receptor expression in human cerebral arteriovenous malformations.

T Hashimoto1, C W Emala, S Joshi, R Mesa-Tejada, C M Quick, L Feng, A Libow, D A Marchuk, W L Young.   

Abstract

OBJECTIVE: Human cerebral arteriovenous malformations (AVMs) are speculated to result from abnormal angiogenesis. Vascular endothelial growth factor receptors (VEGF-Rs) and Tie-2 play critical roles in vasculogenesis and angiogenesis. We hypothesized that the abnormal vascular phenotype of AVMs may be associated with abnormal expression of VEGF-Rs and Tie-2.
METHODS: We measured the expression of Tie-2, VEGF-R1, and VEGF-R2 in AVMs and normal brain tissue, using immunoblotting. To assess active vascular remodeling, we also measured endothelial nitric oxide synthase expression. CD31 expression was used to control for endothelial cell mass for Tie-2, VEGF-Rs, and endothelial nitric oxide synthase. Immunoblotting data were presented as relative expression, using normal brain tissue values as 100%.
RESULTS: CD31 was expressed to similar degrees in AVMs and normal brain tissue (99+/-29% versus 100+/-20%, mean +/- standard error, P = 0.98). Tie-2 expression was markedly decreased in all AVMs, compared with normal brain tissue (16+/-9% versus 100+/-37%, P = 0.04). VEGF-R1 expression was decreased in four of five AVMs, but the difference between the mean values was not significant (35+/-8% versus 100+/-42%, P = 0.14). VEGF-R2 expression was decreased in all AVMs, compared with normal brain tissue (28+/-6% versus 100+/-29%, P = 0.03). There was no difference in endothelial nitric oxide synthase expression between AVMs and normal brain tissue (106+/-42% versus 100+/-25%, P = 0.91).
CONCLUSION: AVM vessels exhibited abnormal expression of Tie-2 and VEGF-Rs, both of which may contribute to the pathogenesis of AVMs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11014431     DOI: 10.1097/00006123-200010000-00022

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  21 in total

Review 1.  Intracranial aneurysms: links among inflammation, hemodynamics and vascular remodeling.

Authors:  Tomoki Hashimoto; Hui Meng; William L Young
Journal:  Neurol Res       Date:  2006-06       Impact factor: 2.448

2.  Increased expression of ephrin A1 in brain arteriovenous malformation: DNA microarray analysis.

Authors:  Atsushi Sasahara; Hidetoshi Kasuya; Hiroyuki Akagawa; Hiroshi Ujiie; Osami Kubo; Toshiyuki Sasaki; Hideaki Onda; Yoshiko Sakamoto; Boris Krischek; Tomokatsu Hori; Ituro Inoue
Journal:  Neurosurg Rev       Date:  2007-06-19       Impact factor: 3.042

3.  Congenital Retinal Macrovessel and the Association of Retinal Venous Malformations With Venous Malformations of the Brain.

Authors:  Francesco Pichi; K Bailey Freund; Antonio Ciardella; Mariachiara Morara; Emad B Abboud; Nicola Ghazi; Christine Dackiw; Netan Choudhry; Eduardo Cunha Souza; Leonardo Provetti Cunha; J Fernando Arevalo; T Y Alvin Liu; Adam Wenick; Lingmin He; Guadalupe Villarreal; Piergiorgio Neri; David Sarraf
Journal:  JAMA Ophthalmol       Date:  2018-04-01       Impact factor: 7.389

4.  Evidence of endothelial progenitor cells in the human brain and spinal cord arteriovenous malformations.

Authors:  Peng Gao; Yongmei Chen; Michael T Lawton; Nicholas M Barbaro; Guo-Yuan Yang; Hua Su; Feng Ling; William L Young
Journal:  Neurosurgery       Date:  2010-10       Impact factor: 4.654

5.  Cerebral arteriovenous fistulas induced by dural arteriovenous shunts.

Authors:  C W Lai; R Agid; R van den Berg; K Ter Brugge
Journal:  AJNR Am J Neuroradiol       Date:  2005-05       Impact factor: 3.825

6.  Transdural blood supply to cerebral arteriovenous malformations adjacent to the dura mater.

Authors:  Michael Söderman; Georges Rodesch; Pierre Lasjaunias
Journal:  AJNR Am J Neuroradiol       Date:  2002-09       Impact factor: 3.825

7.  Biological activity of paediatric cerebral cavernomas: an immunohistochemical study of 28 patients.

Authors:  Wuttipong Tirakotai; Sandra Fremann; Niels Soerensen; Wolfgang Roggendorf; Adrian M Siegel; Hans Dieter Mennel; Yuan Zhu; Helmut Bertalanffy; Ulrich Sure
Journal:  Childs Nerv Syst       Date:  2006-02-18       Impact factor: 1.475

8.  Soluble endoglin modulates aberrant cerebral vascular remodeling.

Authors:  Yongmei Chen; Qi Hao; Helen Kim; Hua Su; Michelle Letarte; S Ananth Karumanchi; Michael T Lawton; Nicholas M Barbaro; Guo-Yuan Yang; William L Young
Journal:  Ann Neurol       Date:  2009-07       Impact factor: 10.422

Review 9.  Microcomputed tomography characterization of neovascularization in bone tissue engineering applications.

Authors:  Simon Young; James D Kretlow; Charles Nguyen; Alex G Bashoura; L Scott Baggett; John A Jansen; Mark Wong; Antonios G Mikos
Journal:  Tissue Eng Part B Rev       Date:  2008-09       Impact factor: 6.389

10.  Bevacizumab attenuates VEGF-induced angiogenesis and vascular malformations in the adult mouse brain.

Authors:  Espen J Walker; Hua Su; Fanxia Shen; Vincent Degos; Gregory Amend; Kristine Jun; William L Young
Journal:  Stroke       Date:  2012-05-08       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.